-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Vertex Pharmaceuticals Inc / Ma quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2010 to Q1 2024.
- Vertex Pharmaceuticals Inc / Ma Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was $1.31B, a 45.2% increase year-over-year.
- Vertex Pharmaceuticals Inc / Ma annual Net Cash Provided by (Used in) Operating Activities for 2023 was $3.54B, a 14.3% decline from 2022.
- Vertex Pharmaceuticals Inc / Ma annual Net Cash Provided by (Used in) Operating Activities for 2022 was $4.13B, a 56.2% increase from 2021.
- Vertex Pharmaceuticals Inc / Ma annual Net Cash Provided by (Used in) Operating Activities for 2021 was $2.64B, a 18.7% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)